Nikolai E. Kudashkin

Nikolai E. Kudashkin

Auto-generated profile, based on publicly available information

Nikolai E. Kudashkin

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2018 in PeerJ
Verified
Journal Article
Open access
PDF file
MCMikhail Chesnokov
Mikhail Chesnokov
PKPolina A. Khesina
Polina A. Khesina
DSDarya A. Shavochkina
Darya A. Shavochkina
IKInna F. Kustova
Inna F. Kustova
LDLeonid M. Dyakov
Leonid M. Dyakov
NLNatalia L. Lazarevich
Natalia L. Lazarevich
Background: Hepatocellular carcinoma (HCC) is the most common and aggressive type of malignant liver tumor. HCC progression depends significantly on its vascularization and formation of new blood vessels. Vascular endothelial growth factor A (VEGFA) is a crucial regulator of tumor vascularization and components of VEGF-induced cell signaling pathways are important targets of therapeutical drugs that demonstrated the highest efficiency in case of advanced HCC (sorafenib and regorafenib). VEGFA is expressed as a set of isoforms with different functional properties, thus VEGFA isoform expression pattern may affect tumor sensitivity to anti-angiogenic drugs. However, information about VEGFA isoforms expression in HCC is still incomplete and contradictory. The present study aims to quantitatively investigate VEGFA isoform expression aberrations in HCC tissue. Methods: A total of 50 pairs of HCC and non-tumor tissue samples were used to evaluate the VEGFA isoform spectrum using RT-PCR and quantitatively estimate changes in isoform expression using RT-qPCR. Correlations between these changes and tumor clinicopathological characteristics were analyzed. Results: We identified VEGFA-189, VEGFA-165, and VEGFA-121 as predominant isoforms in liver tissue. Anti-angiogenic VEGFA-xxxb variants constituted no more than 5% of all mature VEGFA transcripts detected and their expression was not changed significantly in HCC tissue. We demonstrated for the first time that the least active variant VEGFA-189 is frequently repressed in HCC (p < 0.001), while no uniform changes were detected for potent angiogenesis stimulators VEGFA-165 and VEGFA-121. Isoform balance in HCC shifts from VEGFA-189 towards VEGFA-165 or VEGFA-121 in the majority of cases (p < 0.001). Changes in fractions, but not expression levels, of VEGFA-189 (decrease) and VEGFA-121 (increase) correlated with advanced Tumor-Node-Metastasis (TNM) and Barcelona Clinic Liver Cancer (BCLC) tumor stages (p < 0.05), VEGFA-189 fraction reduction was also associated with poor tumor differentiation (p < 0.05). Discussion: A distinct shift in VEGFA isoform balance towards more pro-angiogenic variants occurs in HCC tissue and may modulate overall impact of VEGFA signaling. We suppose that the ratio between VEGFA isoforms is an important parameter governing HCC angiogenesis that may affect HCC progression and be used for optimizing the strategy of HCC therapy by predicting the response to anti-angiogenic drugs.

23 April 2023 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
APA.N. Polyakov
A.N. Polyakov
YPYu.I. Patyutko
Yu.I. Patyutko
NKN.E. Kudashkin
N.E. Kudashkin
DKD.M. Kantieva
D.M. Kantieva
KRK.A. Romanova
K.A. Romanova
DPD.V. Podluzhnyi
D.V. Podluzhnyi
ЦЕЛЬ ИССЛЕДОВАНИЯ Определить целесообразность необратимой электропорации (НЭП) при местно-распространенной аденокарциноме поджелудочной железы на основе собственного опыта и данных литературы. МАТЕРИАЛ И МЕТОДЫ С 2015 по 2022 г. 23 пациентам выполнена НЭП по поводу местно-распространенного рака поджелудочной железы после индукционной химиотерапии. НЭП чаще проводили во время лапаротомии (n=22). В 1 случае ее сочетали с паллиативной панкретодуоденальной резекцией. После процедуры адъювантную химиотерапию получили 19 (86,3%) пациентов. Контрольное обследование включало КТ/МРТ брюшной полости с внутривенным контрастированием, рентгенографию или КТ органов грудной клетки, определение опухолевого маркера CA 19-9 через 1 мес после операции, затем каждые 3 мес. РЕЗУЛЬТАТЫ Осложнения после НЭП развились у 5 (21,7%) пациентов. У 3 (13,0%) больных отмечена аритмия, у 3 (8,7%) — панкреонекроз. Девяностодневная летальность после процедуры составила 4,3% (n=1), причина — панкреонекроз. По интраоперационным данным и результатам первого обследования (КТ/МРТ) весь опухолевый инфильтрат был обработан в 21 (91,3%) случае. Медиана времени наблюдения составила 19 мес. Медиана времени до местного рецидива составила 15 мес. Изолированный локальный рецидив наблюдался у 7 больных, 3 из них проведена лучевая терапия, 1 — повторная НЭП. Отдаленные метастазы обнаружены у 11 больных; системная терапия была возобновлена. Медиана времени до прогрессирования составила 7 мес после НЭП и 14 мес после начала индукционной химиотерапии. Медиана общей выживаемости составила 16 мес после электропорации и 25 мес после индукционной химиотерапии. ЗАКЛЮЧЕНИЕ Необратимая электропорация может быть применима у тщательно отобранных пациентов с местно-распространенной аденокарциномой поджелудочной железы после успешной индукционной химиотерапии. Метод обеспечивает локальный контроль, но влияние на отдаленные результаты и целесообразность рутинного использования следует определить в рандомизированных исследованиях.

20 September 2022 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
AKAlexey Kotelnikov
Alexey Kotelnikov
YPYu. I. Patyutko
Yu. I. Patyutko
DPD. V. Podluzhny
D. V. Podluzhny
MSM. S. Saakyan
M. S. Saakyan
NKN. E. Kudashkin
N. E. Kudashkin
ЮПЮ. И. Патютко
Ю. И. Патютко
The paper presents the results of various studies and meta-analyses which focus on assessing the frequency of formation of clinically significant pancreatic fistulas in various types of pancreatic-digestive anastomoses. Pancreatodigestive anastomosis is not an independent predictive factor of pancreatic complications. None of the modern types of pancreatodigestive anastomosis has proved its superiority. The choice of the pancreatodigestive anastomosis method is based on the correct selection of the organ with which the pancreatic stump is connected and the surgeon’s experience and skill in forming the anastomosis.

1 January 2016 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
YPYu. I. Patyutko
Yu. I. Patyutko
NKN. E. Kudashkin
N. E. Kudashkin
AKA. G. Kotel’nIkov
A. G. Kotel’nIkov
OCO. V. Chistyakova
O. V. Chistyakova
To determine the indications and to evaluate early and long-term outcomes of total pancreatectomy for pancreatic cancer. Treatment of 29 patients who underwent one- and two-stage pancreatectomy for different malignancies was analyzed. Median of surgery duration and intraoperative blood loss was 280 min and 2200 ml respectively. Postoperative complications were observed in 9 (31%) patients. There were 2 (6.9%) deaths. 1- and 3-year overall actual survival was 61% and 16% respectively in case of ductal adenocarcinoma. Median was 18 months. Patients after surgery for primary multiple lesion (cancer of pancreatic body-tail and major duodenal papilla), pancreatic metastases of renal cancer, mucinous cystadenoma and neuroendocrine cancer are still alive. Follow-up periods are 4, 49, 49 and 65 months respectively. Total pancreatectomy is difficult intervention followed by severe metabolic disorders. However it can improve long-term survival with acceptable incidence of postoperative complications and quality of life if clear indications for surgery are present.

20 April 2018 in Journal of Gastrointestinal Cancer
Verified
Journal Article
Closed access
PDF file
IPIlya A. Pokataev
Ilya A. Pokataev
AKAsel Kudaibergenova
Asel Kudaibergenova
AAAnna Artemyeva
Anna Artemyeva
APAnna Popova
Anna Popova
ARAlexey Rumyantsev
Alexey Rumyantsev
STSergey Tjulandin
Sergey Tjulandin

19 March 2023 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
AKAlexey Kotelnikov
Alexey Kotelnikov
YPY. I. Patyutko
Y. I. Patyutko
DPD. V. Podluzhnyi
D. V. Podluzhnyi
MSM. S. Saakyan
M. S. Saakyan
NKN. E. Kushlinski
N. E. Kushlinski
ЮПЮ. И. Патютко
Ю. И. Патютко
At present, pancreaticoduodenoctomy causes the high incidence of complications. However, it is associated with an acceptable level of postoperative mortality. With this regard and taking into consideration a significant increase in survival in pancreatic cancer, it is highly relevant to study the negative functional outcomes of surgery and develop methods for their surgical prevention. The bibliographic review focuses on the features of three main postsurgical syndromes: gastric stasis, pancreatic exocrine and endocrine insufficiency. The study shows the dependence of these syndromes on pathomorphological characteristics of pancreatic stump, preservation of the pyloric, the variant of pancreatodigestive anastomosis and other features of reconstructive stage of the surgery.